Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,965 | -13,007 | -11,660 | -20,983 | -18,972 |
| Depreciation Amortization | 1 | -149 | -180 | -72 | 256 |
| Accounts payable and accrued liabilities | 415 | 511 | 73 | 352 | -261 |
| Other Working Capital | 1,521 | 469 | -1,994 | 1,636 | -1,940 |
| Other Operating Activity | 3,725 | 510 | 1,682 | 2,364 | 2,634 |
| Operating Cash Flow | $-15,303 | $-11,666 | $-12,079 | $-16,702 | $-18,282 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -60 |
| Purchase Of Investment | -6,315 | -16,852 | -25,553 | -33,056 | -25,272 |
| Sale Of Investment | 10,208 | 19,850 | 36,839 | 36,182 | 28,568 |
| Other Investing Activity | 0 | 0 | 7 | 0 | -7 |
| Investing Cash Flow | $3,893 | $2,998 | $11,293 | $3,126 | $3,229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 234 | N/A | 10,000 | N/A | N/A |
| Debt Repayment | -1,667 | -3,333 | N/A | N/A | N/A |
| Common Stock Issued | 22,332 | 13,652 | 652 | 11,226 | 606 |
| Financing Cash Flow | $20,899 | $10,319 | $10,652 | $11,226 | $606 |
| Beginning Cash Position | 14,729 | 13,078 | 3,211 | 5,561 | 20,008 |
| End Cash Position | 24,217 | 14,729 | 13,078 | 3,211 | 5,561 |
| Net Cash Flow | $9,489 | $1,651 | $9,867 | $-2,350 | $-14,447 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,303 | -11,666 | -12,079 | -16,702 | -18,282 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -60 |
| Free Cash Flow | -15,303 | -11,666 | -12,079 | -16,702 | -18,342 |